Betamethasone Ointment

Betamethasone Ointment Market Outlook

The global Betamethasone Ointment market was valued at approximately USD 1.1 billion in 2022 and is projected to reach around USD 1.6 billion by 2033, growing at a CAGR of about 4.5% during the forecast period from 2025 to 2033. This growth is attributed to increasing incidences of skin disorders, such as dermatitis, psoriasis, and eczema, which are prevalent across various demographics. Additionally, the rising awareness regarding the efficacy of topical corticosteroids like Betamethasone and the expanding geriatric population, which is more susceptible to skin ailments, further propel the demand for Betamethasone Ointments. Moreover, the development of advanced formulations and the advent of online pharmacies have contributed significantly to market growth, making these products more accessible to patients globally.

Growth Factor of the Market

The Betamethasone Ointment market is primarily driven by the increasing prevalence of dermatological conditions, which are often exacerbated by environmental factors, lifestyle choices, and genetic predisposition. The ability of Betamethasone to effectively alleviate inflammation, redness, and pain associated with various skin conditions has made it a preferred choice among healthcare professionals. Furthermore, the surge in healthcare expenditure and the growing trend towards self-medication are also significant contributors to the market expansion. The rise of telemedicine platforms has simplified consultations with dermatologists, widening the consumer base for Betamethasone Ointment. Additionally, the pharmaceutical industry's focus on research and development to enhance the formulation of Betamethasone products, ensuring better absorption and reduced side effects, continues to stimulate market growth.

Key Highlights of the Market

• The Betamethasone Ointment market is witnessing a robust growth rate, driven by the increasing cases of skin disorders.
• Technological advancements in drug formulations are resulting in enhanced product efficacy and patient compliance.
• The online pharmacy segment is expanding, providing easier access to Betamethasone products.
• North America holds a significant share of the market, attributed to higher healthcare spending and awareness among the population.
• Emerging markets in Asia Pacific are expected to witness substantial growth due to increasing disposable incomes and healthcare infrastructure improvements.

By Product Type

Cream:

Betamethasone cream is a popular formulation used for treating various inflammatory skin conditions due to its ease of application and faster absorption. The cream form is preferred for moist and weeping lesions, as it provides a cooling sensation upon application, which helps alleviate itching and discomfort. The demand for Betamethasone cream is notably high among consumers seeking quick relief from conditions like eczema and dermatitis. Moreover, the convenience of cream formulations, which can be easily applied and absorbed without leaving a greasy residue, makes them highly desirable. As a result, this product type continues to dominate the Betamethasone market segment.

Lotion:

Betamethasone lotion is particularly favored for use on larger body areas and hairy regions, where creams may not be practical. The lightweight nature of lotions allows for easy spreadability and absorption, making it suitable for individuals with oily skin or those who prefer a less viscous product. Additionally, lotions are often recommended for conditions where a non-greasy finish is desired. With the increasing incidence of skin disorders requiring prolonged treatment, the demand for Betamethasone lotion is likely to see an upward trajectory as consumers look for effective yet comfortable treatment options.

Gel:

Betamethasone gel formulations have gained popularity due to their fast-drying properties and cooling sensation, which provide immediate relief from itching and irritation. Gels are typically utilized for their non-greasy texture and are particularly effective for treating localized inflammation. The convenience of gel applications makes them a preferred choice for younger demographics and active individuals. Furthermore, the growing awareness of the benefits of gel formulations in the management of skin conditions is likely to bolster their market share within the Betamethasone product segment.

Spray:

Betamethasone sprays are increasingly being used for their ease of application, especially in hard-to-reach areas of the body. The spray formulation eliminates the need for direct contact with the affected area, which can be particularly beneficial for conditions like psoriasis where lesions may be widespread. The convenience of a spray allows patients to administer treatment independently, contributing to improved adherence to therapy. As awareness of this formulation increases, along with its advantages, the market for Betamethasone sprays is poised for growth.

Ointment:

Betamethasone ointments are highly concentrated formulations that provide long-lasting relief for severe skin conditions. The occlusive nature of ointments allows for enhanced penetration of the active ingredient, making them particularly effective for chronic conditions requiring intensive treatment. Ointments are often preferred for dry and scaly lesions, as they provide moisturization while delivering the medication. The enduring effectiveness and patient satisfaction associated with ointment formulations underpin their significant role in the Betamethasone market segment.

By Application

Dermatitis:

Dermatitis, a prevalent skin condition characterized by inflammation, redness, and itching, is a major application area for Betamethasone Ointments. The anti-inflammatory properties of Betamethasone make it a first-line treatment for various types of dermatitis, including atopic and contact dermatitis. The increasing incidence of dermatitis globally, driven by environmental allergens and irritants, is expected to boost the demand for Betamethasone products specifically formulated for this application. Furthermore, ongoing research into the effectiveness of Betamethasone in managing dermatitis continues to underscore its importance in dermatological care.

Psoriasis:

Psoriasis is a chronic, autoimmune skin disorder that manifests as red, scaly patches on the skin, significantly impacting the quality of life of affected individuals. Betamethasone is often prescribed as part of a comprehensive treatment regimen to reduce inflammation and plaque formation associated with psoriasis. Given the rising prevalence of psoriasis globally, coupled with the push for effective management strategies, the application of Betamethasone Ointments in treating this condition presents a significant market opportunity. Healthcare providers' focus on individualized treatment plans incorporating topical corticosteroids like Betamethasone will further enhance its usage in psoriasis management.

Eczema:

Eczema, a condition that affects millions worldwide, is marked by itchy and inflamed skin. Betamethasone Ointments are commonly employed to alleviate symptoms and control flare-ups, making them a critical treatment option. As the understanding of eczema's triggers and management options evolves, the demand for effective topical solutions continues to rise. The growing emphasis on early intervention and effective management strategies for eczema will likely sustain the upward trajectory of Betamethasone use in this application area, particularly among pediatric populations who are often more susceptible to eczema.

Skin Allergies:

Skin allergies can manifest in various forms, including rashes, itching, and swelling, often requiring prompt treatment to alleviate discomfort and prevent further complications. Betamethasone is widely recognized for its efficacy in managing allergic reactions and inflammatory responses. As awareness of allergens increases globally, the prevalence of skin allergies is on the rise, leading to an increased demand for effective treatments such as Betamethasone Ointments. The growing trend towards natural and holistic health practices will also encourage patients to seek reliable topical corticosteroids for managing allergic reactions, thereby supporting market growth.

Others:

The 'Others' segment encompasses various skin conditions not classified under the primary applications listed above, such as insect bites, sunburn, and localized infections. Betamethasone Ointments may be utilized in these scenarios to manage inflammation and promote healing. The versatility of Betamethasone as a topical treatment opens pathways for its application in addressing non-specific dermatological issues. As healthcare providers increasingly recognize the breadth of conditions that can benefit from Betamethasone treatment, this segment will contribute to the overall growth of the Betamethasone Ointment market.

By Distribution Channel

Hospital Pharmacies:

Hospital pharmacies play a crucial role in the distribution of Betamethasone Ointments, particularly for patients requiring specialized care for skin conditions. These pharmacies offer a wide range of Betamethasone formulations as part of comprehensive treatment regimens for hospitalized patients, ensuring timely access to critical medications. The growth of hospital pharmacies stems from the increasing patient population and the prioritization of specialized dermatological treatments in hospital settings. Furthermore, collaborations between hospitals and pharmaceutical companies to enhance patient outcomes through effective medication management will continue to bolster the market share of Betamethasone Ointments distributed through these channels.

Retail Pharmacies:

Retail pharmacies serve as a primary source for consumers seeking Betamethasone Ointments for self-treatment of common dermatological conditions. The accessibility and convenience of retail pharmacies make them an attractive option for consumers, allowing them immediate access to needed medications without requiring a prescription. The rising trend of over-the-counter Betamethasone products has further increased the market presence of these ointments in retail settings. Retail pharmacies' ongoing efforts to educate consumers about the proper use of Betamethasone products will likely enhance their sales and market penetration.

Online Pharmacies:

The rise of e-commerce has revolutionized the way consumers purchase medications, and Betamethasone Ointments are no exception. Online pharmacies offer convenience and discretion, enabling consumers to browse and purchase medications from the comfort of their homes. The growing adoption of digital health platforms and telehealth services has driven the demand for Betamethasone products in the online pharmacy segment. Furthermore, online pharmacies often provide valuable information regarding product usage and potential side effects, fostering informed decision-making among consumers. This trend is expected to continue, as more people shift towards e-commerce for their healthcare needs, thereby expanding the availability of Betamethasone Ointments.

Drug Stores:

Drug stores are an essential distribution channel for Betamethasone Ointments, providing a wide array of health and wellness products to consumers. These stores offer convenience and accessibility, making it easy for individuals to find the medications they need for various skin conditions. The competitive pricing and promotional activities often employed by drug stores contribute to their attractiveness as a point of sale for Betamethasone products. The continued expansion of drug store chains and their focus on providing comprehensive skincare solutions will further enhance the market presence of Betamethasone Ointments.

Others:

The 'Others' distribution channel segment includes alternative outlets such as health food stores, clinics, and dermatology clinics, where Betamethasone Ointments may be available. These channels often cater to specific demographics or niche markets, offering personalized service and expert advice on skin care. The diversification of distribution channels is essential for reaching a broader audience and ensuring that Betamethasone products are accessible to those in need. The growth of this segment will depend on the increasing recognition of the importance of dermatological health and the willingness of various outlets to stock effective treatment options like Betamethasone Ointments.

By Ingredient Type

Betamethasone Dipropionate:

Betamethasone dipropionate is one of the most commonly used forms of Betamethasone in topical ointments due to its potent anti-inflammatory properties. This ingredient is particularly effective in treating moderate to severe skin conditions, making it a preferred choice among dermatologists. The effectiveness of Betamethasone dipropionate in managing conditions such as psoriasis and dermatitis has led to its widespread adoption in various formulations. As a result, products containing this ingredient are expected to hold a significant share of the Betamethasone Ointment market, driven by ongoing clinical research and positive patient outcomes.

Betamethasone Valerate:

Another widely used ingredient in Betamethasone Ointments is betamethasone valerate, known for its ability to reduce inflammation and alleviate itching associated with various skin disorders. Its efficacy in treating conditions like eczema and allergic reactions makes it a staple in dermatological formulations. The increasing demand for topical corticosteroids that provide rapid relief has bolstered the market for Betamethasone valerate-based products. Furthermore, ongoing research into the formulation of this ingredient may lead to enhanced products that improve patient compliance and treatment efficacy.

Betamethasone Acetate:

Betamethasone acetate is another key ingredient utilized in Betamethasone Ointments, appreciated for its effectiveness against localized skin conditions. Its formulation allows for precise targeting of inflamed areas, making it a popular choice among healthcare providers. The growing prevalence of skin disorders requiring localized treatment is expected to drive demand for Betamethasone acetate products, with healthcare professionals increasingly recognizing its role in managing chronic skin conditions. As the understanding of ingredient efficacy continues to evolve, the market for Betamethasone acetate formulations is anticipated to expand.

Betamethasone Sodium Phosphate:

Betamethasone sodium phosphate is recognized for its rapid action and effectiveness in reducing inflammation and itching. It is often used in combination with other Betamethasone formulations to enhance the overall therapeutic effect. The versatility of this ingredient allows for its application across various skin disorders, ensuring comprehensive treatment options for patients. The growing inclination towards combination therapies in dermatology is likely to augment the presence of Betamethasone sodium phosphate-based products within the market. Additionally, ongoing clinical studies focusing on its efficacy may further solidify its position as a valuable ingredient.

Others:

The 'Others' segment includes various lesser-known formulations and combinations of Betamethasone ingredients that contribute to specialized treatments. This may encompass products tailored for specific skin types or unique dermatological conditions. The ongoing innovation in pharmaceutical formulations is expected to yield new and effective products, expanding the market scope for Betamethasone Ointments. The diversity in ingredient types caters to the varying needs of patients, ensuring that effective treatment options are available for a wide range of skin disorders.

By Region

The North American region is a significant player in the Betamethasone Ointment market, accounting for approximately 35% of the total market share in 2022. The high prevalence of skin disorders, coupled with advanced healthcare infrastructure and increased healthcare spending, has bolstered the demand for Betamethasone products in this region. Additionally, North America boasts a robust market for dermatological treatments, with widespread availability of Betamethasone Ointments through various distribution channels. The growth in this region is projected to continue at a CAGR of 4.2% until 2033, supported by ongoing research initiatives and rising public awareness regarding skin health.

In Europe, the Betamethasone Ointment market is also witnessing substantial growth, fueled by rising incidences of skin conditions like eczema and psoriasis. This region holds a market share of approximately 30%, with countries like Germany and the UK leading the way in terms of consumption. The increasing emphasis on dermatological health and the availability of various Betamethasone formulations have made it a popular choice among healthcare providers and patients alike. The European market is expected to witness a steady growth rate of around 4.0% during the forecast period, as advancements in healthcare technology and increased accessibility to medications continue to enhance market dynamics.

Opportunities

One of the most promising opportunities in the Betamethasone Ointment market lies in the increasing demand for dermatological treatments driven by rising awareness of skin health. As consumers become more educated about the importance of early intervention in skin disorders, there is potential for significant growth in the market for Betamethasone Ointments. This demand is particularly pronounced among younger populations who prioritize skincare and are more inclined to seek effective treatments for conditions like acne, eczema, and dermatitis. Furthermore, the rise of telemedicine has made it easier for patients to consult with dermatologists, leading to greater diagnoses and treatment plans that incorporate Betamethasone products. The convergence of these trends presents a valuable opportunity for market players to innovate and expand their product offerings to meet the evolving needs of consumers.

Another opportunity lies in the expansion of online pharmacy platforms, which are rapidly gaining traction among consumers. The convenience of purchasing medications online allows for greater access to Betamethasone Ointments, particularly in regions where traditional pharmacies may be less accessible. The ongoing digitization of healthcare services and the growing trend towards e-commerce are expected to create a favorable environment for the sales of Betamethasone products. Pharmaceutical companies that invest in establishing a strong online presence and collaborating with digital health platforms will be better positioned to capitalize on this trend, ultimately enhancing their market share and presence in the Betamethasone Ointment sector.

Threats

Despite the promising growth prospects, the Betamethasone Ointment market faces several threats that could impact its trajectory. One significant challenge is the increasing competition from generic formulations that provide similar therapeutic benefits at lower price points. As patents for branded Betamethasone products expire, the entry of generic competitors may lead to price erosion, reducing overall market revenues. Furthermore, the growing trend of self-medication may result in patients opting for over-the-counter alternatives without proper medical guidance, potentially leading to misuse and adverse effects. Such factors could constrain the growth of the Betamethasone market, necessitating strategic responses from market players.

Additionally, regulatory challenges and stringent guidelines surrounding the approval of topical corticosteroids could pose a restraining factor for the market. The need for extensive clinical trials and regulatory compliance may delay the introduction of new formulations, hindering innovation within the sector. These regulatory hurdles can also limit the ability of smaller companies to compete effectively, consolidating the market power among larger players. As the landscape evolves, stakeholders will need to navigate these challenges while continuing to deliver effective Betamethasone solutions to consumers.

Competitor Outlook

• GlaxoSmithKline
• Pfizer
• Novartis
• Bristol-Myers Squibb
• Teva Pharmaceuticals
• Hikma Pharmaceuticals
• Sanofi
• AstraZeneca
• Dermira, Inc.
• Amgen
• AbbVie
• Johnson & Johnson
• Valeant Pharmaceuticals
• Sun Pharmaceutical Industries
• Mylan N.V.

The competitive landscape of the Betamethasone Ointment market is characterized by a mix of established pharmaceutical companies and emerging players striving to innovate and capture market share. Major players such as GlaxoSmithKline and Pfizer dominate the market with their well-established product lines and extensive distribution networks. These companies leverage their research capabilities and financial strength to invest in the development of new formulations and delivery systems for Betamethasone, ensuring they maintain a competitive edge. Furthermore, their ability to navigate regulatory challenges and secure patents for new products has allowed them to retain significant market share.

Emerging companies like Dermira, Inc. and Amgen are also making strides in the Betamethasone market by focusing on niche applications and patient-centered formulations. These companies often prioritize research and development to create innovative solutions that cater to specific patient needs, such as formulations designed for sensitive skin or combination therapies that enhance treatment efficacy. The competitive advantage of these emerging players lies in their agility and responsiveness to market trends, which allows them to quickly adapt to changing consumer demands and capitalize on opportunities.

Moreover, partnerships and collaborations between pharmaceutical companies and healthcare providers are becoming increasingly common in the Betamethasone Ointment market. These collaborations aim to enhance patient education and improve adherence to treatment regimens, ultimately fostering better health outcomes. By aligning their interests with those of healthcare professionals, companies can position their products more effectively in the market, leveraging the trust and endorsement of clinicians to drive sales. Overall, the competitive landscape of the Betamethasone Ointment market is dynamic, with ongoing innovation and strategic alliances shaping its future.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Amgen
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 AbbVie
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Pfizer
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Sanofi
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Novartis
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Mylan N.V.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 AstraZeneca
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Dermira, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 GlaxoSmithKline
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Johnson & Johnson
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Bristol-Myers Squibb
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Teva Pharmaceuticals
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Hikma Pharmaceuticals
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Valeant Pharmaceuticals
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Sun Pharmaceutical Industries
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Betamethasone Ointment Market, By Application
    • 6.1.1 Dermatitis
    • 6.1.2 Psoriasis
    • 6.1.3 Eczema
    • 6.1.4 Skin Allergies
    • 6.1.5 Others
  • 6.2 Betamethasone Ointment Market, By Product Type
    • 6.2.1 Cream
    • 6.2.2 Lotion
    • 6.2.3 Gel
    • 6.2.4 Spray
    • 6.2.5 Ointment
  • 6.3 Betamethasone Ointment Market, By Ingredient Type
    • 6.3.1 Betamethasone Dipropionate
    • 6.3.2 Betamethasone Valerate
    • 6.3.3 Betamethasone Acetate
    • 6.3.4 Betamethasone Sodium Phosphate
    • 6.3.5 Others
  • 6.4 Betamethasone Ointment Market, By Distribution Channel
    • 6.4.1 Hospital Pharmacies
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Pharmacies
    • 6.4.4 Drug Stores
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Betamethasone Ointment Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Betamethasone Ointment market is categorized based on

By Product Type

• Cream
• Lotion
• Gel
• Spray
• Ointment

By Application

• Dermatitis
• Psoriasis
• Eczema
• Skin Allergies
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores
• Others

By Ingredient Type

• Betamethasone Dipropionate
• Betamethasone Valerate
• Betamethasone Acetate
• Betamethasone Sodium Phosphate
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• GlaxoSmithKline
• Pfizer
• Novartis
• Bristol-Myers Squibb
• Teva Pharmaceuticals
• Hikma Pharmaceuticals
• Sanofi
• AstraZeneca
• Dermira, Inc.
• Amgen
• AbbVie
• Johnson & Johnson
• Valeant Pharmaceuticals
• Sun Pharmaceutical Industries
• Mylan N.V.